RNA Interference based Midkine Gene Therapy for Hepatocellular Carcinoma

Bibliographic Information
Authors: Mamdouh S.; Khorshed F.E.-Z.M.; Hammad G.; Magdy M.; Abdelraouf A.; Hemida E.; Shemis M.
Journal: Asian Pacific Journal of Cancer Prevention
Publisher: Asian Pacific Organization for Cancer Prevention
Publication Date: 1 July 2024
Volume / Issue: Volume 25 / Issue 7
Pages: 2371–2379
ISSN: 15137368
DOI: 10.31557/APJCP.2024.25.7.2371
Scopus: View on Scopus
PubMed: 39068570
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Mamdouh S., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Khorshed F.E.-Z.M., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt; Hammad G., Faculty of Biotechnology, October University for Modern Sciences & Arts (MSA), Giza, Egypt; Magdy M., Department of Pathology, Theodor Bilharz Research Institute, Cairo, Egypt; Abdelraouf A., Department of Hepatobiliopancreatic Surgery, National Hepatology and Tropical Medicine Research Institute, (NHTMRI), Cairo, Egypt; Hemida E., Fellow of Biochemistry, Obstetrics and Gynecology Hospital, Ain Shams University, Cairo, Egypt; Shemis M., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute (TBRI), Giza, Egypt
Abstract
Background: Hepatocellular carcinoma (HCC) arises from hepatocytes and accounts for 90% of primary liver cancer. Reasons for HCC prognosis remaining dismal are that HCC is asymptomatic in its early stages, leading to late diagnosis, and it is markedly resistant to conventional chemo- and radiotherapy. In this study, we investigated RNA interference (RNAi)–based treatment for HCC by targeting MDK. Aim: The present study aimed to evaluate MDK serum levels as a diagnostic biomarker for HCC detection and the effect of MDK silencing by RNAi on HCC. Subjects and methods: A total of 140 participants, including 120 patients diagnosed with HCC and 20 healthy volunteers were enrolled in this study, all patients who underwent liver resection were sampled for tumor and adjacent non-tumor liver tissues, in addition to 5 ml of blood sample. Midkine expression levels were evaluated by ELISA and by qRT-PCR. The in vitro transfection and gene knockdown efficiency of midkine by MDK-siRNA was detected by qRT-PCR and ELISA. Gene knockdown effect at the molecule level on the proliferation of HepG2 in vitro was determined by cell counting. Results: The results showed that the expression of MDK was significantly increased in the serum of HCC patients compared to control serum samples with P<0.001 and significant elevated expression levels of MDK in tumor tissues compared to non-tumor ones with P<0.001. It also showed that down-regulation of MDK using RNAi can significantly inhibit HepG2 cells. Conclusion: Molecular targeting of MDK using RNAi interference decreases proliferation and could be a therapeutic target. © (2024), (Asian Pacific Organization for Cancer Prevention). All rights reserved.
Keywords
gene therapy; HCC; Midkine; RNAi; Adult; Biomarkers, Tumor; Carcinoma, Hepatocellular; Case-Control Studies; Cell Proliferation; Female; Follow-Up Studies; Genetic Therapy; Hep G2 Cells; Humans; Liver Neoplasms; Male; Middle Aged; Prognosis; RNA Interference; RNA, Small Interfering; Tumor Cells, Cultured; MDK protein, human; small interfering RNA; tumor marker; blood; case control study; follow up; genetics; Hep-G2 cell line; human; liver cell carcinoma; liver tumor; pathology; procedures; therapy; tumor cell culture
Citation Information
Scopus Citations: 2
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
